Dr. O'Brien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
135 Rutledge Ave
Ste 1201
Charleston, SC 29425Phone+1 843-792-2295Fax+1 843-792-7771
Summary
- I am a board certified cardiologist who practices all aspects of non-invasive cardiology. I am also active in clinical trials and have a basic science laboratory that examines models of heart failure.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1988 - 1990
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1984 - 1987
- University of California San Diego School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1988 - Present
- SC State Medical License 1993 - 2025
- TX State Medical License 1985 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 227 citationsThe Effect of Alagebrium Chloride (ALT-711), a Novel Glucose Cross-Link Breaker, in the Treatment of Elderly Patients With Diastolic Heart FailureWilliam C. Little, Michael R. Zile, Dalane W. Kitzman, W. Gregory Hundley, Terrence X. O'Brien
Journal of Cardiac Failure. 2005-04-01 - 70 citationsA multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in pa...James E. Udelson, Martin Bilsker, Paul J. Hauptman, Rafael F. Sequeira, Ignatius Thomas
Journal of Cardiac Failure. 2011-12-01 - 42 citationsEffects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled StudyPaul W. Ladenson, Madeline McCarren, Eugene Morkin, Robert Edson, Mei Chiung Shih
The Journal of Clinical Endocrinology and Metabolism. 2010-03-01
Grant Support
- Conduction System Remodeling After Myocardial InfarctionVeterans Affairs2011
- Core--Morphology And Molecular ImagingNational Heart, Lung, And Blood Institute2003–2007
- Oxidative Phosphorylation In Cardiac HypertrophyNational Heart, Lung, And Blood Institute1996–2000
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: